Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Cumberland Pharmaceuticals Inc. (CPIX)

4.6900 +0.3400 (+7.82%)
At close: October 30 at 4:00:01 PM EDT
4.6101 -0.0799 (-1.70%)
After hours: October 30 at 5:49:24 PM EDT
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
44,304.3140
44,521.4310
37,867.9450
39,552.5070
42,010.9490
Cost of Revenue
6,736.5890
6,667.2070
6,585.9720
6,066.6110
9,118.5210
Gross Profit
35,335.2240
37,854.2240
31,281.9730
33,485.8960
32,892.4280
Operating Expense
40,679.4350
40,646.2170
37,714.3820
43,040.5570
38,597.3570
Operating Income
-3,042.3280
-2,791.9930
-6,432.4090
-9,554.6610
-5,704.9290
Net Non Operating Interest Income Expense
-129.4520
-19.2420
-271.0640
-381.0070
-487.5900
Other Income Expense
--
--
237.0890
3,650.6710
611.3300
Pretax Income
-3,171.7800
-2,811.2350
-6,466.3840
-6,284.9970
-5,581.1890
Tax Provision
36.6560
40.2560
-22.6690
45.7690
68.8500
Earnings from Equity Interest Net of Tax
--
-13.2200
0
--
--
Net Income Common Stockholders
-10,918.4720
-2,836.1280
-6,479.7700
-6,279.3200
-5,570.2410
Diluted NI Available to Com Stockholders
-10,918.4720
-2,836.1280
-6,479.7700
-6,279.3200
-5,570.2410
Basic EPS
-0.73
-0.19
-0.46
-0.44
-0.38
Diluted EPS
-0.73
-0.19
-0.46
-0.44
-0.38
Basic Average Shares
14,864.2980
14,854.6190
14,060.2720
14,298.7740
14,563.5920
Diluted Average Shares
14,864.2980
14,854.6190
14,060.2720
14,298.7740
14,563.5920
Total Operating Income as Reported
-3,042.3280
-2,791.9930
-6,432.4090
-9,554.6610
-5,704.9290
Total Expenses
47,346.6420
47,313.4240
44,300.3540
49,107.1680
47,715.8780
Net Income from Continuing & Discontinued Operation
-10,918.4720
-2,836.1280
-6,479.7700
-6,279.3200
-5,570.2410
Normalized Income
-3,200.9590
-2,836.1280
-6,716.0529
-6,928.5420
-6,053.1917
Interest Income
362.4650
476.7480
334.4440
286.8540
98.4050
Interest Expense
491.9170
495.9900
605.5080
667.8610
585.9950
Net Interest Income
-129.4520
-19.2420
-271.0640
-381.0070
-487.5900
EBIT
-2,679.8630
-2,315.2450
-5,860.8760
-5,617.1360
-4,995.1940
EBITDA
2,599.9250
2,970.6930
182.4220
2,485.5120
332.9190
Reconciled Cost of Revenue
5,467.4670
5,415.9260
5,290.9260
8,398.8050
8,857.7760
Reconciled Depreciation
5,279.7880
5,285.9380
6,043.2980
5,770.4540
5,328.1130
Net Income from Continuing Operation Net Minority Interest
-3,200.9590
-2,836.1280
-6,479.7700
-6,279.3200
-5,570.2410
Total Unusual Items Excluding Goodwill
0
0
237.0890
821.8000
611.3300
Total Unusual Items
0
0
237.0890
821.8000
611.3300
Normalized EBITDA
2,599.9250
2,970.6930
-54.6670
1,663.7120
-278.4110
Tax Rate for Calcs
0.0004
0.0002
0
0.0002
0.0002
Tax Effect of Unusual Items
0
0
0.8061
172.5780
128.3793
12/31/2022 - 8/11/2009

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: